ATP5IF1 and bacterial infectious disease: Remarkably, whereas 90% of control mice tolerated the DSS-treatment only 33% of IF1-KO mice survived (Figure 4B), supporting the idea that the CD4+ guided adaptive immune response is compromised in IF1-KO mice upon a bacterial infection.